
Adastra Holdings — Investor Relations & Filings
Adastra Holdings is a manufacturer and supplier of ethnobotanical and cannabis products for the lawful adult-use and medical markets. The company specializes in the extraction and processing of cannabis, offering a portfolio that includes concentrates, vape pens, wax, resin, and infused pre-rolls. Adastra manufactures products for its proprietary brands, such as Phyto Extractions and Endgame Extracts, and provides co-manufacturing services for partners. A core operational advantage is the co-location of Adastra Labs with Chemia Analytics, an in-house licensed analytical testing and consulting laboratory. This integrated facility ensures rigorous quality control, compliance, and efficient product development, emphasizing a scientific and refined approach to extraction methodologies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-04 | English | |
| Material change report - English.pdf | 2026-05-04 | English | |
| Material change report - English.pdf | 2026-04-29 | English | |
| News release - English.pdf | 2026-04-29 | English | |
| News release - English.pdf | 2026-03-02 | English | |
| Material change report - English.pdf | 2026-03-02 | English |
Browse filings by year
28 years- 2026 6 filings
- 2025 29 filings
- 2024 35 filings
- 2023 46 filings
- 2022 45 filings
- 2021 88 filings
- 2020 60 filings
- 2019 21 filings
- 2018 23 filings
- 2017 13 filings
- 2016 31 filings
- 2015 17 filings
- 2014 1 filing
- 2013 5 filings
- 2012 8 filings
- 2011 14 filings
- 2010 4 filings
- 2009 5 filings
- 2008 2 filings
- 2007 14 filings
- 2006 6 filings
- 2005 3 filings
- 2004 1 filing
- 2003 1 filing
- 2002 1 filing
- 2000 3 filings
- 1999 5 filings
- 1998 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 47487391 | News release - English.pdf | 2026-05-04 | English | ||
| 47487394 | Material change report - English.pdf | 2026-05-04 | English | ||
| 47487399 | Material change report - English.pdf | 2026-04-29 | English | ||
| 47487422 | News release - English.pdf | 2026-04-29 | English | ||
| 47487425 | News release - English.pdf | 2026-03-02 | English | ||
| 47487430 | Material change report - English.pdf | 2026-03-02 | English | ||
|
2025
9 filings
| |||||
| 47487434 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2025-12-01 | English | ||
| 47487439 | Interim MD&A - English.pdf | 2025-12-01 | English | ||
| 32350530 | Other.pdf | 2025-10-29 | English | ||
| 32350529 | Other.pdf | 2025-10-29 | English | ||
| 32350528 | Form of proxy - English.pdf | 2025-10-29 | English | ||
| 32350527 | Management information circular - English.pdf | 2025-10-29 | English | ||
| 32350526 | Notice of meeting - English.pdf | 2025-10-29 | English | ||
| 32340924 | News release - English.pdf | 2025-10-16 | English | ||
| 47487469 | Material change report - English.pdf | 2025-10-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Innovations Inc.
Develops, manufactures, and sells science-based natural hea…
|
ATB | CA | Manufacturing |
|
Atrium Therapeutics, Inc.
Pioneering precision RNA medicines for cardiac diseases, fo…
|
RNA | US | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
Adastra Holdings via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44131/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44131 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44131 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44131 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44131}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Adastra Holdings (id: 44131)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.